[Production of recombinant protein of Tyr p 32 from <i>Tyrophagus putrescentiae</i> and identifying its immunoreactivity].

The present study was aimed to produce the recombinant protein of <i>Tyrophagus putrescentiae</i> allergen component 32 (Tyr p 32) and to identify its immunoreactivity. The cDNA encoding Tyr p 32 was amplified from total RNA of <i>T. putrescentiae</i> and inserted into pET-28a (+) vector. The constructed plasmid pET-28a (+)-Tyr p 32 was transformed into BL21 (DE3) receptor cells. After being induced with IPTG, the recombinant protein was purified with Ni column, and then identified on SDS-PAGE and Western blotting. Serum of children with allergic asthma and(or) rhinitis was collected, IgE-ELISA and IgE-Western blotting were used to detect the binding rate of rTyr p 32 to human <i>T.putrescentiae-</i>positive serum. After human bronchial epithelial cells BEAS-2B being cultured with rTyr p 32, the expression levels of IL-6 and IL-8 cytokines was detected by ELISA and qRT-PCR, t-test was used for pairwise comparison between groups. The results showed that the cDNA length of Tyr p 32 was 885 bp. The sequence identity between Tyr p 32 and Der p 32, Der f 32 was 70.21% and 68.03%, respectively. According to SDS-PAGE and Western blotting, the molecular weight of rTyr p 32 was about 35 000 Da, which was consistent with the theoretical value. IgE-ELISA results showed that the positive rate of rTyr p 32 was 41.38% (12/29) against <i>T. putrescentiae</i>-positive serum. When BEAS-2B cells were cultured with rTyr p 32, the expression of IL-6 and IL-8 increased in the cell supernatant in a dose-dependent manner (<i>t</i>=-29.10,<i>P</i>=0.001 2;<i>t</i>=-33.69,<i>P</i>=0.000 9), which also significantly increased the mRNA expression levels of IL-6 and IL-8 (<i>t</i>=-9.15,<i>P</i>=0.011 7;<i>t</i>=-17.16,<i>P</i>=0.003 4). In conclusion, the recombinant protein rTyr p 32 was successfully prepared, which provides raw materials for component diagnosis and specific immunotherapy of allergic diseases.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-12-06
DOI
https://doi.org/10.3760/cma.j.cn112150-20231225-00485
Primary Topic
Cancer Research and Treatments
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Production of recombinant protein of Tyr p 32 from Tyrophagus putrescentiae and identifying its immunoreactivity].

Yubao Cui, Ying Zhou, Yaning Ren, Dongmei Zhou et al.
PubMed
Cancer Research and Treatments
article

[Production of recombinant protein of Tyr p 32 from Tyrophagus putrescentiae and identifying its immunoreactivity].

Yubao Cui, Ying Zhou, Yaning Ren, Dongmei Zhou, Yanfen Liao
article en

Abstract

The present study was aimed to produce the recombinant protein of <i>Tyrophagus putrescentiae</i> allergen component 32 (Tyr p 32) and to identify its immunoreactivity. The cDNA encoding Tyr p 32 was amplified from total RNA of <i>T. putrescentiae</i> and inserted into pET-28a (+) vector. The constructed plasmid pET-28a (+)-Tyr p 32 was transformed into BL21 (DE3) receptor cells. After being induced with IPTG, the recombinant protein was purified with Ni column, and then identified on SDS-PAGE and Western blotting. Serum of children with allergic asthma and(or) rhinitis was collected, IgE-ELISA and IgE-Western blotting were used to detect the binding rate of rTyr p 32 to human <i>T.putrescentiae-</i>positive serum. After human bronchial epithelial cells BEAS-2B being cultured with rTyr p 32, the expression levels of IL-6 and IL-8 cytokines was detected by ELISA and qRT-PCR, t-test was used for pairwise comparison between groups. The results showed that the cDNA length of Tyr p 32 was 885 bp. The sequence identity between Tyr p 32 and Der p 32, Der f 32 was 70.21% and 68.03%, respectively. According to SDS-PAGE and Western blotting, the molecular weight of rTyr p 32 was about 35 000 Da, which was consistent with the theoretical value. IgE-ELISA results showed that the positive rate of rTyr p 32 was 41.38% (12/29) against <i>T. putrescentiae</i>-positive serum. When BEAS-2B cells were cultured with rTyr p 32, the expression of IL-6 and IL-8 increased in the cell supernatant in a dose-dependent manner (<i>t</i>=-29.10,<i>P</i>=0.001 2;<i>t</i>=-33.69,<i>P</i>=0.000 9), which also significantly increased the mRNA expression levels of IL-6 and IL-8 (<i>t</i>=-9.15,<i>P</i>=0.011 7;<i>t</i>=-17.16,<i>P</i>=0.003 4). In conclusion, the recombinant protein rTyr p 32 was successfully prepared, which provides raw materials for component diagnosis and specific immunotherapy of allergic diseases.

PubMedVol. 58(12)
Wuxi Fourth People's Hospital (CN), Jiangxi Provincial Children's Hospital (CN), Wuxi People's Hospital (CN)
Cancer Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.